Check out this blog on GLP1 medications and dietary counseling
Frailty and Semaglutide in metabolic research models-Related HFpEF: Another STEP in [PMID: 40884983] Laboratory literature summary: Frailty and Semaglutide in metabolic research models-Related HFpEF: Another STEP in the Right Direction
Today, there is no scientific evidence that this happens, but a related drug in the class, tirzepatide (Mounjaro, Zepbound), carries warnings on its FDA labels that it may reduce the efficacy of oral hormonal contraceptives due to delayed gastric emptying. Patients are advised to switch to a non-oral form of contraception or to add a barrier method, such as condoms
Compounded preparations combining antimicrobial agents, anti-inflammatory ingredients, and healing promoterstailored to the specific procedure (chemical peel, laser resurfacing, microneedling, excisional surgery)allow prescribers to optimize wound healing rather than relying on generic over-the-counter recovery products
Wang Y, Kelly MA, Cowan TM, Longo N: A missense mutation in the OCTN2 gene associated with residual carnitine transport activity
These capacities created are likely to be utilised better as the demand for GLP-1 increases